Effects of an Inpatient Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease (COPD) III/IV

Chronic Obstructive Pulmonary Disease Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01418768
• Other study ID #: CAT2011
• Status: Completed
• Phase: N/A
• First received: August 9, 2011
• Last updated: February 1, 2013
• Start date: August 2011
• Est. completion date: December 2012

Study information

• Verified date: February 2013
• Source: Klinikum Berchtesgadener Land der Schön-Kliniken
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if there is a change in the CAT-score after an inpatient rehabilitation of three weeks and if it correlates with other common parameters.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: December 2012
• Est. primary completion date: September 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 75 Years

Eligibility

Inclusion Criteria:

• inpatient rehabilitation in Schön Klinik Berchtesgadener Land

• stable COPD(GOLD severity III and IV with and without respiratory insufficiency)

Exclusion Criteria:

• severe exacerbation in the last four weeks

• acute coronary syndrome

• unability to cooperate

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• inpatient rehabiliation
inpatient, multimodal, individual workout including endurance training, strength training, coordination training etc. for three weeks.

Locations

Country	Name	City	State
Germany	Schön Klinik Berchtesgadener Land	Schönau am Königssee

Sponsors (1)

Lead Sponsor	Collaborator
Klinikum Berchtesgadener Land der Schön-Kliniken

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in CAT-score		day 1 to day 21	Yes
Secondary	Change in 6 minutes walking distance		day 1 to day 21	No
Secondary	Change in Short-Form 36		day 1 to day 21	No
Secondary	Change in Hospital Anxiety and Depression Scale		day 1 to day 21	No
Secondary	Change in diffusing capacity		day 1 to day 21	No
Secondary	Change in forced expiratory volume in 1 second (FEV1)		day 1 to day 21	No
Secondary	Change in Body Mass index		day 1 to day 21	No
Secondary	Change in basal energy rate		day 1 to day 21	No
Secondary	Change in BODE-Index		day 1 to day 21	No
Secondary	Change in St. George's Respiratory Questionaire		Day 1 to day 21	No